findmyKOL

Daniel Venarske, MD

Basic profile

University of Mississippi

ORCIDNone on fileNPI↗
✓ Full record
RegionJackson, MS · SoutheastSpecialtyAllergy & ImmunologyFocusRheumatology/Immunology
Active KOLfindmyKOL type: RegionalLatest publication2007Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Daniel Venarske is a Rheumatology/Immunology physician affiliated with University of Mississippi. OpenAlex indexes 8 publications with 269 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
8publications

Distinct works indexed by OpenAlex.

269citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
36companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1513 Lakeland Dr.
Suite 101
Jackson, MS 39216

Telephone

601-354-4836

Registry record last updated 28 Jan 2010.

View the NPPES registry record

Industry payments

36 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    82%
    Corticosteroid34.6%
    Fluticasone Propionate52%Trelegy Ellipta17%Breo Ellipta9%Symbicort6%Breyna6%Dulera4%Breztri Aerosphere4%Mometasone Furoate3%
    Part D<11 patients
    Leukotriene Receptor Antagonist20.1%
    Montelukast Sodium100%
    Part D≥62 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    12.9%
    H2 blocker7.5%
    Famotidine100%
    Part D≥28 patients
    Corticosteroid5.4%
    Prednisone100%
    Part D≥46 patients
  • Anti-infectives

    3.9%
    Macrolide Antimicrobial2.4%
    Azithromycin100%
    Part D≥23 patients
    Penicillins with extended spectrum1.5%
    Amoxicillin-Clavulanate Potass100%
    Part D≥16 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 8 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”